{"id":250780,"date":"2022-09-01T00:00:00","date_gmt":"2022-09-01T00:00:00","guid":{"rendered":"https:\/\/clarivate.com\/products\/research-reports\/report\/epidon0212-biopharma-nk-t-cell-lymphoma-epidemiology-extrapolated\/"},"modified":"2026-04-24T05:19:56","modified_gmt":"2026-04-24T05:19:56","slug":"epidon0212-biopharma-nk-t-cell-lymphoma-epidemiology-extrapolated-worldwide-coverage","status":"publish","type":"report","link":"https:\/\/clarivate.com\/life-sciences-healthcare\/report\/epidon0212-biopharma-nk-t-cell-lymphoma-epidemiology-extrapolated-worldwide-coverage\/","title":{"rendered":"NK\/T-Cell Lymphoma &#8211; Epidemiology &#8211; Extrapolated Worldwide Coverage"},"content":{"rendered":"<p>Clarivate\u2019s extended worldwide coverage is the first and only evidence-based data set of epidemiological forecasts for key NK\/T-cell patient populations covering 171 countries and more than 99% of the global population, delivered in an interactive dashboard-style download. Use the extended worldwide coverage data set to:<\/p>\n<ul class=\"round-bullets\">\n<li>View 10-year forecasts of the diagnosed prevalent cases and diagnosed incident cases for all 171 countries, stratified by region and World Bank income status.<\/li>\n<li>Aggregate country-level estimates into region-level estimates, according to user preference or as required by regulators for orphan drug designations.<\/li>\n<li>Visualize global correlations between disease risk or patient population size and key indicators of market opportunity such as <abbr title=\"gross domestic product\">GDP<\/abbr> per capita and healthcare spend per capita.<\/li>\n<li>Generate and export global heat maps of disease risk or patient population size.<\/li>\n<\/ul>\n<p>The extended worldwide coverage dashboard is available as an Excel file in the \u201cDownloads\u201d section. It is available only to clients with subscriptions to all 45 countries covered by <abbr title=\"Decision Resources Group\">C<\/abbr>larivate Epidemiology. For subscription and entitlement queries, please contact <a href=\"mailto:healthcare.support@clarivate.com\" target=\"_blank\">healthcare.support@clarivate.com<\/a>.<\/p>\n","protected":false},"template":"","class_list":["post-250780","report","type-report","status-publish","hentry","report-gateway-biopharma","biopharma-therapy-areas-hematological-malignancies","biopharma-therapy-areas-hematology","biopharma-product-epidemiology","biopharma-date-960"],"acf":[],"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/250780","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report"}],"about":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/types\/report"}],"version-history":[{"count":2,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/250780\/revisions"}],"predecessor-version":[{"id":517312,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/250780\/revisions\/517312"}],"wp:attachment":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/media?parent=250780"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}